Xiaoyong Ge

1.3k total citations · 2 hit papers
20 papers, 716 citations indexed

About

Xiaoyong Ge is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xiaoyong Ge has authored 20 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Xiaoyong Ge's work include Cancer-related molecular mechanisms research (5 papers), Ferroptosis and cancer prognosis (4 papers) and RNA modifications and cancer (4 papers). Xiaoyong Ge is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Ferroptosis and cancer prognosis (4 papers) and RNA modifications and cancer (4 papers). Xiaoyong Ge collaborates with scholars based in China, United Kingdom and Australia. Xiaoyong Ge's co-authors include Xinwei Han, Chunguang Guo, Yuqing Ren, Zaoqu Liu, Peng Luo, Libo Wang, Quan Cheng, Yi Zhang, Siyuan Weng and Long Liu and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Xiaoyong Ge

19 papers receiving 706 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunosenescence: molecular mechanisms and diseases

2023 421 citations Zaoqu Liu, Yuqing Ren et al. Signal Transduction and Targeted Therapy profile →
Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy

2023 84 citations Zaoqu Liu, Yuqing Ren et al. Molecular Cancer profile →

Peers

Xiaoyong Ge

IMMUN

ONCOL

PRM

Sara Ture United States

Gaurav Kumar United States

Miao‐Tzu Huang Taiwan

William McCormack Ireland

Christophe Carré France

Sameena S. Khan United States

Jeffery C. Rathmell United States

Weiwei Chen China

Sophie Sarret Switzerland

Katarzyna Barczyk‐Kahlert Germany

Sara Ture United States

Xiaoyong Ge

252 ×0.9

267 ×1.2

IMMUN

112 ×0.7

ONCOL

56 ×0.5

80 ×0.8

PRM

Citations per year, relative to Xiaoyong Ge Xiaoyong Ge (= 1×) peers Sara Ture

Countries citing papers authored by Xiaoyong Ge

Since Specialization

Citations

This map shows the geographic impact of Xiaoyong Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyong Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyong Ge more than expected).

Fields of papers citing papers by Xiaoyong Ge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyong Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyong Ge. The network helps show where Xiaoyong Ge may publish in the future.

Co-authorship network of co-authors of Xiaoyong Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyong Ge. A scholar is included among the top collaborators of Xiaoyong Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyong Ge. Xiaoyong Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Qili, Qingqing Xiao, Minjie Yang, et al.. (2025). LncRNA OIP5-AS1 promotes immune evasion in abdominal aortic aneurysm cells by recruiting MDSCs and inhibiting CD8 + T cells through STK24 upregulation. Cytotechnology. 77(3). 102–102.

Ren, Kewei, Jianan Wang, Yahua Li, et al.. (2024). Paclitaxel-coated balloon catheter for benign esophageal stenosis in a rabbit model. Scientific Reports. 14(1). 2551–2551. 1 indexed citations

Ba, Yuhao, Shutong Liu, Tong Qiao, et al.. (2024). Pyroptosis-Derived Long Noncoding RNA Profiles Reveal a Novel Signature for Evaluating the Prognosis of Patients With Lung Adenocarcinoma. JCO Precision Oncology. 8(8). e2300405–e2300405. 1 indexed citations

Liu, Zaoqu, Yuqing Ren, Chunguang Guo, et al.. (2023). Immunosenescence: molecular mechanisms and diseases. Signal Transduction and Targeted Therapy. 8(1). 200–200. 421 indexed citations breakdown →

Ren, Kewei, Yahua Li, Kunpeng Wu, et al.. (2023). Bevacizumab-loaded CalliSpheres beads: in vitro loading, release profiles and application in rabbit liver VX2 tumor model. Frontiers in Oncology. 13. 1153759–1153759. 2 indexed citations

Li, Yahua, Xiaoyong Ge, Zongming Li, et al.. (2023). Application of temperature-sensitive liquid embolic agent loaded with oxaliplatin in the TACE procedure for rabbit VX2 gastric cancer. Drug Delivery and Translational Research. 14(3). 705–717. 3 indexed citations

Liu, Zaoqu, Yuqing Ren, Hui Xu, et al.. (2023). Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy. Molecular Cancer. 22(1). 35–35. 84 indexed citations breakdown →

Ge, Xiaoyong, Hui Xu, Siyuan Weng, et al.. (2023). Systematic analysis of transcriptome signature for improving outcomes in lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 149(11). 8951–8968. 2 indexed citations

Wu, Kunpeng, Yahua Li, Zongming Li, et al.. (2023). Transcatheter arterial chemoembolization combined with apatinib and camrelizumab for unresectable advanced gastric or gastroesophageal junction cancer: a single-arm, single-center, retrospective study. Frontiers in Oncology. 13. 1143578–1143578. 1 indexed citations

10.

Liu, Zaoqu, Long Liu, Siyuan Weng, et al.. (2023). BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors. Journal Of Big Data. 10(1). 65 indexed citations

11.

Xu, Hui, Zaoqu Liu, Siyuan Weng, et al.. (2022). Artificial intelligence‐driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi‐center integration analysis. Molecular Oncology. 16(22). 4023–4042. 21 indexed citations

12.

Xing, Zhe, Zaoqu Liu, Xudong Fu, et al.. (2022). Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma. Frontiers in Cell and Developmental Biology. 10. 805291–805291. 12 indexed citations

13.

Liu, Yiying, Taoyuan Lu, Zaoqu Liu, et al.. (2022). Six macrophage-associated genes in synovium constitute a novel diagnostic signature for osteoarthritis. Frontiers in Immunology. 13. 936606–936606. 32 indexed citations

14.

Guo, Chunguang, Zaoqu Liu, Yu Yin, et al.. (2022). Integrated Analysis of Multi-Omics Alteration, Immune Profile, and Pharmacological Landscape of Pyroptosis-Derived lncRNA Pairs in Gastric Cancer. Frontiers in Cell and Developmental Biology. 10. 816153–816153. 16 indexed citations

15.

Weng, Siyuan, Zaoqu Liu, Xiaofeng Ren, et al.. (2022). SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer. Frontiers in Immunology. 13. 873871–873871. 18 indexed citations

16.

Ge, Xiaoyong, Zaoqu Liu, Siyuan Weng, et al.. (2022). Integrative pharmacogenomics revealed three subtypes with different immune landscapes and specific therapeutic responses in lung adenocarcinoma. Computational and Structural Biotechnology Journal. 20. 3449–3460. 4 indexed citations

17.

Weng, Siyuan, Zaoqu Liu, Hui Xu, et al.. (2022). ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer. Frontiers in Immunology. 13. 910582–910582. 12 indexed citations

18.

Liu, Zaoqu, Siyuan Weng, Chunguang Guo, et al.. (2022). Machine learning algorithm-generated and multi-center validated melanoma prognostic signature with inspiration for treatment management. Cancer Immunology Immunotherapy. 72(3). 599–615. 5 indexed citations

19.

Liu, Zaoqu, Hui Xu, Xiaoyong Ge, et al.. (2022). Gene Expression Profile Reveals a Prognostic Signature of Non–MSI-H/pMMR Colorectal Cancer. Frontiers in Cell and Developmental Biology. 10. 6 indexed citations

20.

Ge, Xiaoyong, Yuan Yao, Jing Li, Zhaonan Li, & Xinwei Han. (2021). Role of LncRNAs in the Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 690800–690800. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact